LivePerson And 2 Other Stocks Under $2 Insiders Are Buying
Portfolio Pulse from Avi Kapoor
Insiders at Cartesian Therapeutics, Aware, and LivePerson have recently made significant stock purchases, signaling potential confidence in their companies' futures. Cartesian Therapeutics saw a large buy from Director Timothy A Springer, with HC Wainwright & Co. maintaining a $2 price target. Aware's CEO and President Robert A Eckel also made a notable purchase, despite a year-over-year decrease in Q4 EPS results. LivePerson's Director Vanessa Pegueros bought shares after the company reported mixed Q4 results and lower than expected 2024 revenue guidance.
March 19, 2024 | 11:55 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
CEO and President Robert A Eckel's acquisition of 13,735 shares at $1.67 each, despite a year-over-year decrease in Q4 EPS results, shows a potential turnaround belief.
The insider purchase by the CEO, despite recent negative EPS results, could indicate an internal belief in a future recovery or undervaluation of AWRE's stock.
CONFIDENCE 75
IMPORTANCE 70
RELEVANCE 80
POSITIVE IMPACT
Director Vanessa Pegueros' purchase of 5,000 shares at $1.02 each after mixed Q4 results and lower 2024 revenue guidance suggests a long-term growth belief.
The insider buying activity following mixed financial results and disappointing future revenue guidance might indicate that insiders believe the stock is undervalued or expect future improvement.
CONFIDENCE 80
IMPORTANCE 75
RELEVANCE 80
POSITIVE IMPACT
Director Timothy A Springer's purchase of 1,185,872 shares at $0.56 each, with a maintained $2 price target by HC Wainwright & Co., suggests strong insider confidence.
The significant insider purchase combined with a positive analyst outlook from HC Wainwright & Co. indicates a bullish sentiment for RNAC's stock in the short term.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 90